ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕

Considering Clinical Trials: A Blog About Cancer Treatment Options
November 3, 2025
November 3, 2025
Categories
  • Editorials

Beating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trials

An inspiring interview with a 13-year survivor of stage 4 pancreas cancer
Do you like it?
0 Read more
November 3, 2025
November 3, 2025
Categories
  • Editorials

What a difference patients make: Honoring the impact of cancer clinical trial participants

ECOG-ACRIN’s Trial Results Summaries Project aims to inform participants of study findings and express gratitude for their contributions to cancer research
Do you like it?
0 Read more
November 3, 2025
November 3, 2025
Categories
  • New Trials

Now Enrolling: The EAA241 research study is exploring a new treatment approach for patients with newly diagnosed myeloma and kidney failure

This clinical trial aims to improve results with a set of medicines that will treat myeloma and reverse kidney failure at the same time
Do you like it?
0 Read more
November 3, 2025
Patient and doctor talking over clipboard
November 3, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditions

For Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions
Do you like it?
0 Read more
November 3, 2025
Research dictionary entry
November 3, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Fall 2025

The latest discoveries from breast, leukemia, lung, nose/sinus, skin, and throat cancer clinical trials
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Tags

Acute lymphoblastic leukemia Adolescents and young adults Advocacy Bladder cancer Breast cancer Caregiving Communication De-escalation Head and neck cancer Health equity HER2+ breast cancer Immune system therapy Immunotherapy In memory Kidney cancer Leukemia Lung cancer Lymphoma Mammography Mantle cell lymphoma Melanoma Multiple myeloma Myeloma NCI-MATCH Nose and sinus cancer Pancreatic cancer Pancreatic cysts Patient care Personalized medicine Personalized screening Personalized treatment Precision medicine Prevention Prostate cancer Renal cell carcinoma Research results Sarcoma Screening Side effects Squamous cell carcinoma Surveillance Survivorship Symptom management Targeted therapy Throat cancer

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc